Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Deubiquitinating Enzyme (DUB) Inhibitors
Sort By
Newest First
1 / 1
1 / 1
Collaboration
FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors
Forma Therapeutics
PR-M05-18-NI-051
May 14, 2018
